Chaitanya Divgi

Targeted α particle immunotherapy for myeloid leukemia

Joseph G. Jurcic, Steven M. Larson, George Sgouros et al. · Blood · 2002 · 465 citations · Full text

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial

Chaitanya Divgi, Neeta Pandit‐Taskar, Achim A. Jungbluth et al. · The Lancet Oncology · 2007 · 383 citations

Preoperative Characterisation, Urology, Surgical Oncology +8

Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung Carcinoma

Chaitanya Divgi, S. Welt, Mark G. Kris et al. · JNCI Journal of the National Cancer Institute · 1991 · 300 citations

Murine Monoclonal Antibody, Medicine, Immunology +15

Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of ²¹¹At-MX35 F(ab′)₂—A Phase I Study

Håkan Andersson, Elin Cederkrantz, Tom Bäck et al. · Journal of Nuclear Medicine · 2009 · 279 citations · Full text

The SNMMI Practice Guideline for Therapy of Thyroid Disease with ¹³¹I 3.0

Edward B. Silberstein, Abass Alavi, Helena Balon et al. · Journal of Nuclear Medicine · 2012 · 276 citations · Full text

Snmmi Practice Guideline, United States, Risk Levels……2 Iv +19